• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet Microbe . H9N2 avian influenza viruses: challenges and the way forward

tetano

Editor, Senior Moderator
Lancet Microbe


. 2022 Nov 10;S2666-5247(22)00305-6.
doi: 10.1016/S2666-5247(22)00305-6. Online ahead of print.
H9N2 avian influenza viruses: challenges and the way forward


Jiahao Zhang[SUP] 1 [/SUP], Lihong Huang[SUP] 1 [/SUP], Ming Liao[SUP] 2 [/SUP], Wenbao Qi[SUP] 3 [/SUP]



Affiliations

No abstract available

Conflict of interest statement

We declare no competing interests. We acknowledge the authors, originating and submitting laboratories of the sequences from the Global Initiative on Sharing All Influenza Data (GISAID)'s EpiFlu Database on which this research is based. All submitters of data can be contacted directly through the GISAID website (www.gisaid.org). This Correspondence was supported by National Natural Science Foundation of China (grant numbers 31830097 and 31672586), and Young Scholars of Yangtze River Scholar Professor Program (2019 WQ). JZ, ML, and WQ planned and conceptualised the laboratory work, and wrote the Correspondence. JZ and LH conducted the virus isolation from samples, antigenic analysis, animal experiments, and sequenced the genomes. ML and WQ provided the funding.
 
hat tip @ButlerJohnW for an added emphasis on lack of vaccine efficacy in H9N2 vaccines

snip

Therefore, the antigenic mutations of H9N2 viruses should also be taken into consideration when choosing the vaccine strains. The pandemic potential of H9N2 viruses is shown by the constant emergence of human-infecting influenza viruses with the internal genes of H9N2,[SUP]2[/SUP] demonstrating that stopping the generation of novel human-infecting avian influenza viruses at their origin is urgently needed. We strongly advise that more attention be given to the prevention and control of H9N2 viruses, not only to enhance the ongoing H9N2 surveillance of birds and high-density at-risk human populations, but also to develop universal H9N2 vaccines.

https://www.thelancet.com/journals/l...305-6/fulltext
 
Back
Top Bottom